Solena undertakes a new challenge. Illumina, Inc. (NASDAQ: ILMN) has selected seven genomics startups to join Illumina Accelerator’s 3rd global funding cycle. The company’s global company creation engine has been focused on creating partnerships with entrepreneurs in order to build innovative genomics startups, in this cycle, Illumina invested in four companies located in Cambridge, UK, and three companies at the San Francisco Bay Area.